Influenza A H1 BY PCR

The Influenza A H1 BY PCR test is a molecular diagnostic assay that detects the genetic material (RNA) of the Influenza A H1 virus from respiratory specimens. Performed using real‑time PCR technology in UAE‑accredited laboratories, it provides high sensitivity and specificity for confirming active infection. At‑home sample collection by a trained healthcare professional in Dubai offers convenience while minimizing exposure to others.

This test is recommended to confirm infection in symptomatic individuals, guide timely antiviral treatment, and inform public health actions during suspected outbreaks. Results are typically returned within 24–48 hours depending on lab turnaround times in Dubai; note that accuracy depends on proper sampling and testing within the optimal window (usually within the first week of symptoms), and false negatives can occur if collected too early or late in the illness.

• Influenza A (H1) viral RNA
• Cycle threshold (Ct) value
• Internal control (sample integrity)
• Result interpretation (Detected / Not detected)

• Onset of fever with cough, sore throat, body aches or shortness of breath
• Worsening respiratory symptoms or clinical deterioration
• High‑risk individuals (young children, elderly, pregnant, chronic illness)
• Close contact with a confirmed Influenza A (H1) case
• During suspected cluster or community outbreak

• High‑accuracy molecular detection using PCR
• Convenient at‑home collection by trained staff in Dubai
• Rapid, certified lab processing and reliable reporting
• Minimizes exposure by avoiding clinic visits
• Actionable results to support clinical management and public health

• At‑home nasopharyngeal or throat swab collected by a trained technician
• No fasting required; avoid nasal sprays or strong decongestants 1–2 hours before collection
• Ideal testing within 1–7 days of symptom onset for best sensitivity